Skip to content
GLP-1 Scorecard
Menu
Site position #161

VyrarX

Published by GLP-1 ScorecardUpdated

VyrarX is a LegitScript-certified telehealth platform offering compounded semaglutide (from $179/month) and compounded tirzepatide (from $329/month) via weekly injection, prescribed by licensed US physicians.

Visit VyrarXWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$179/mo (starting dose, compounded)
Tirzepatide
$329/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Not confirmed

Weigh VyrarX against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value61/100
Dose & formulation64/100
Clinical oversight84/100
Labs & monitoring72/100
Fulfillment71/100
Contract terms55/100

Strengths

  • LegitScript certified with active seal (ID 51177727)
  • Semaglutide starting at $179/month with free shipping included
  • 1:1 direct provider messaging and personalized titration plan in every plan
  • Nutrition coaching included with the weight-loss program
  • Provider review completed within 24 hours; no insurance required

What to consider

  • Tirzepatide at $329/month starting is at the high end of the compounded market
  • Compounding pharmacy not named on any public page
  • No physician names or clinical leadership disclosed publicly
  • Only 47 states covered — the 3 excluded states are not named on the site
  • Labs not included in the weight-loss plan

Bottom line — Grade C

Best for: Shoppers who want compounded semaglutide ($179/mo) and tirzepatide ($329/mo) via LegitScript-certified telehealth in 47 states.

Site position #161 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest VyrarX — the realistic shortlist.

The 22 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect VyrarX's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on VyrarX's site. Not medical advice; see our disclosure.

← Back to the scorecard